Examination of point mutations within the ABL kinase domain of Bcr-Abl fusion gene in Chinese patients with chronic myeloid leukemia who develop imatinib resistance

被引：0
|
作者：
Yang, Dongguang [1 ]
Zhang, Ri [2 ]
Gang, Honglin [3 ]
Gu, Jian [2 ]
Cen, Jian Nong [2 ]
机构：
[1] Jiang Su Su Bei People Hosp, Yangzhou Inst Hematol, Jiangsu, Peoples R China
[2] Suzhou Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou 215006, Peoples R China
[3] Yangzhou Univ, Dept Pharmacol, Jiangsu, Peoples R China
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4573.4573
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4573
引用
收藏
页码：214B / 215B
页数：2
相关论文
共 50 条
  • [1] Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients
    Chandrasekhar, Chodimella
    Kumar, Pasupuleti Santhosh
    Sarma, Potukuchi Venkata Gurunadha Krishna
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [2] Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients
    Chodimella Chandrasekhar
    Pasupuleti Santhosh Kumar
    Potukuchi Venkata Gurunadha Krishna Sarma
    Scientific Reports, 9
  • [3] Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib
    Chahardouli, Bahram
    Zaker, Farhad
    Mousavi, Seied Asadollah
    Saffari, Zeinab
    Nadali, Fatemeh
    Ostadali, Mohammadreza
    Ghadimi, Habibeh
    Alimoghaddam, Kamran
    Ghavamzade, Ardeshir
    Rostami, Shahrbano
    HEMATOLOGY, 2013, 18 (06) : 327 - 332
  • [4] Characteristics of BCR-ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients
    Qin, YaZhen
    Chen, ShanShan
    Jiang, Bin
    Jiang, Qian
    Jiang, Hao
    Li, JinLan
    Li, LingDi
    Lai, YueYun
    Liu, YanRong
    Huang, XiaoJun
    ANNALS OF HEMATOLOGY, 2011, 90 (01) : 47 - 52
  • [5] Primary imatinib resistance in chronic myeloid leukemia patients in a developing country: BCR-ABL kinase domain mutations or BCR-ABL independent mechanisms?
    Yap, E.
    Tumian, N. R.
    Azma, R. Z.
    Sharifah, N. A.
    Salwati, S.
    Hamidah, N. H.
    Elias, M. H.
    Wong, C. L.
    MALAYSIAN JOURNAL OF PATHOLOGY, 2017, 39 (02) : 107 - 113
  • [6] Characteristics of BCR–ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients
    YaZhen Qin
    ShanShan Chen
    Bin Jiang
    Qian Jiang
    Hao Jiang
    JinLan Li
    LingDi Li
    YueYun Lai
    YanRong Liu
    XiaoJun Huang
    Annals of Hematology, 2011, 90 : 47 - 52
  • [7] BCR-ABL kinase domain mutations in chronic myeloid leukemia - Not quite enough to cause resistance to imatinib therapy?
    Lange, T
    Park, B
    Willis, SG
    Deininger, MWN
    CELL CYCLE, 2005, 4 (12) : 1761 - 1766
  • [8] BCR- ABL KINASE MUTATIONS TO IMATINIB RESISTANCE IN CHRONIC MYELOID LEUKEMIA
    Thungappa, S. Chiradoni
    Singh, T.
    Rashmi, N. R.
    Lokanatha, D.
    Rajshekar, H.
    Lakshmaiah, K. C.
    Babu, K. G.
    Suresh, T. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 357 - 357
  • [9] Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia
    O'Hare, Thomas
    Eide, Christopher A.
    Deininger, Michael W. N.
    BLOOD, 2007, 110 (07) : 2242 - 2249
  • [10] BCR-ABL independent gene mutations in patients with chronic myeloid leukemia
    Schmidt, M.
    Rinke, J.
    Schaefer, V.
    Ziermann, J.
    Eigendorff, E.
    Hochhaus, A.
    Ernst, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 210 - 210
12345